It is additionally accredited for Grown ups who're overweight with a number of bodyweight-linked circumstances, including significant blood pressure or Kind 2 diabetes (significant blood sugar). In March of 2024, the FDA approved an additional indication for Wegovy—to reduce the chance of cardiovascular Dying, coronary heart attack, and stroke in https://glp-1weightlossmed.com/product/wegovy/